Best Practice & Research Clinical Anaesthesiology
Volume 23, Issue 4 , Pages 473-485 , December 2009

Is hypoglycaemia dangerous?

  • Thomas Duning, MD

      Affiliations

    • Department of Neurology, University Hospital of Münster, Albert-Schweitzer-Straße 33, D- 48149 Münster, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49 251 8348196; Fax: +49 251 8348181.
    • ,
  • Björn Ellger, MD

      Affiliations

    • Department of Anesthesiology and Intensive Care Medicine, University Hospital of Münster, Albert-Schweitzer-Straße 33, D- 48149 Münster, Germany
    • Tel.: +49 251 8347252; Fax.: +49 251 88704.

References 

  1. Cryer PE. Hypoglycemia. Pathophysiology, diagnosis and treatment. New York: Oxford Univ. Press; 1997;
  2. Nehlig A. Cerebral energy metabolism, glucose transport and blood flow: changes with maturation and adaptation to hypoglycaemia. Diabetes Metabolism. 1997;23:18–29
  3. Suh SW, Hamby AM, Swanson RA. Hypoglycemia, brain energetics, and hypoglycemic neuronal death. Glia. 2007;55:1280–1286
  4. Lewis LD, Ljunggren B, Ratcheson RA, et al. Cerebral energy state in insulin-induced hypoglycemia, related to blood glucose and to EEG. Journal of Neurochemistry. 1974;23:673–679
  5. Cornblath M, Hawdon JM, Williams AF, et al. Controversies regarding definition of neonatal hypoglycemia: suggested operational thresholds. Pediatrics. 2000;105:1141–1145
  6. Alkalay AL, Flores-Sarnat L, Sarnat HB, et al. Plasma glucose concentrations in profound neonatal hypoglycemia. Clinical Pediatrics (Phila). 2006;45:550–558
  7. Warren RE, Frier BM. Hypoglycaemia and cognitive function. Diabetes, Obesity & Metabolism. 2005;7:493–503
  8. Frier BM. Hypoglycaemia and cognitive function in diabetes. International Journal of Clinical Practice. Supplement. 2001;30–37
  9. McAulay V, Deary IJ, Frier BM. Symptoms of hypoglycaemia in people with diabetes. Diabetes Medicine. 2001;18:690–705
  10. Towler DA, Havlin CE, Craft S, et al. Mechanism of awareness of hypoglycemia. Perception of neurogenic (predominantly cholinergic) rather than neuroglycopenic symptoms. Diabetes. 1993;42:1791–1798
  11. Cryer PE, Davis SN, Shamoon H. Hypoglycemia in diabetes. Diabetes Care. 2003;26:1902–1912
  12. Strachan MW, Deary IJ, Ewing FM, et al. Recovery of cognitive function and mood after severe hypoglycemia in adults with insulin-treated diabetes. Diabetes Care. 2000;23:305–312
  13. Frier BM. Defining hypoglycaemia: what level has clinical relevance?. Diabetologia. 2009;52:31–34
  14. Boyle PJ, Nagy RJ, O'Connor AM, et al. Adaptation in brain glucose uptake following recurrent hypoglycemia. Proceedings of the National Academy of Sciences of the United States of America. 1994;91:9352–9356
  15. Davis MR, Shamoon H. Counterregulatory adaptation to recurrent hypoglycemia in normal humans. The Journal of Clinical Endocrinology and Metabolism. 1991;73:995–1001
  16. Boyle PJ. Alteration in brain glucose metabolism induced by hypoglycaemia in man. Diabetologia. 1997;40(Suppl. 2):S69–S74
  17. Heller SR, Macdonald IA. The measurement of cognitive function during acute hypoglycaemia: experimental limitations and their effect on the study of hypoglycaemia unawareness. Diabetes Medicine. 1996;13:607–615
  18. Deary IJ. Effects of hypoglycaemia on cognitive function. In:  Frier BM,  Fisher BM editor. Hypoglycaemia and diabetes: clinical and physiological aspects. 2nd ed.. London: Ewald Arnold; 1993;p. 80–92
  19. Holmes CS, Hayford JT, Gonzalez JL, et al. A survey of cognitive functioning at difference glucose levels in diabetic persons. Diabetes Care. 1983;6:180–185
  20. McAulay V, Deary IJ, Ferguson SC, et al. Acute hypoglycemia in humans causes attentional dysfunction while nonverbal intelligence is preserved. Diabetes Care. 2001;24:1745–1750
  21. Widom B, Simonson DC. Glycemic control and neuropsychologic function during hypoglycemia in patients with insulin-dependent diabetes mellitus. Annals of Internal Medicine. 1990;112:904–912
  22. Wirsen A, Tallroth G, Lindgren M, et al. Neuropsychological performance differs between type 1 diabetic and normal men during insulin-induced hypoglycaemia. Diabetes Medicine. 1992;9:156–165
  23. Cox DJ, Gonder-Frederick LA, Schroeder DB, et al. Disruptive effects of acute hypoglycemia on speed of cognitive and motor performance. Diabetes Care. 1993;16:1391–1393
  24. Deary IJ, Sommerfield AJ, McAulay V, et al. Moderate hypoglycaemia obliterates working memory in humans with and without insulin treated diabetes. Journal of Neurological Neurosurgery Psychiatry. 2003;74:278–279
  25. Pramming S, Thorsteinsson B, Theilgaard A, et al. Cognitive function during hypoglycaemia in type I diabetes mellitus. British Medical Journal (Clinical Research Edition). 1986;292:647–650
  26. Gordon SM, Jackson JC, Ely EW, et al. Clinical identification of cognitive impairment in ICU survivors: insights for intensivists. Intensive Care Medicine. 2004;30:1997–2008
  27. Hopkins RO, Brett S. Chronic neurocognitive effects of critical illness. Current Opinion of the Critical Care. 2005;11:369–375
  28. Mitrakou A, Ryan C, Veneman T, et al. Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction. American Journal of Physiology. 1991;260:E67–E74
  29. Boeve BF, Bell DG, Noseworthy JH. Bilateral temporal lobe MRI changes in uncomplicated hypoglycemic coma. Canadian Journal of Neurological Science. 1995;22:56–58
  30. Chalmers J, Risk MT, Kean DM, et al. Severe amnesia after hypoglycemia. Clinical, psychometric, and magnetic resonance imaging correlations. Diabetes Care. 1991;14:922–925
  31. Gold AE, Marshall SM. Cortical blindness and cerebral infarction associated with severe hypoglycemia. Diabetes Care. 1996;19:1001–1003
  32. Lo L, Tan AC, Umapathi T, et al. Diffusion-weighted MR imaging in early diagnosis and prognosis of hypoglycemia. AJNR American Journal of Neuroradiology. 2006;27:1222–1224
  33. McCall AL. The impact of diabetes on the CNS. Diabetes. 1992;41:557–570
  34. Perros P, Sellar RJ, Frier BM. Chronic pontine dysfunction following insulin-induced hypoglycemia in an IDDM patient. Diabetes Care. 1994;17:725–727
  35. Fujioka M, Okuchi K, Hiramatsu KI, et al. Specific changes in human brain after hypoglycemic injury. Stroke. 1997;28:584–587
  36. Cubo E, Andres MT, Rojo A, et al. Neuroimaging of hypoglycemia, Revue Neurologique. 1998;26:774–776
  37. Garambois K, Grand S, Jaillard A, et al. Diffusion-weighted magnetic resonance imaging in hypoglycemic coma, Revue Neurologique. 2004;160:575–578
  38. Ho MS, Weller NJ, Ives FJ, et al. Prevalence of structural central nervous system abnormalities in early-onset type 1 diabetes mellitus. Journal of Pediatrics. 2008;153:385–390
  39. Perantie DC, Wu J, Koller JM, et al. Regional brain volume differences associated with hyperglycemia and severe hypoglycemia in youth with type 1 diabetes. Diabetes Care. 2007;30:2331–2337
  40. Kodl CT, Franc DT, Rao JP, et al. Diffusion tensor imaging identifies deficits in white matter microstructure in subjects with type 1 diabetes that correlate with reduced neurocognitive function. Diabetes. 2008;57:3083–3089
  41. Warren RE, Sommerfield AJ, Greve A, et al. Moderate hypoglycaemia after learning does not affect memory consolidation and brain activation during recognition in non-diabetic adults. Diabetes Metabolism Research Reviews. 2008;24:247–252
  42. Auer RN, Wieloch T, Olsson Y, et al. The distribution of hypoglycemic brain damage. Acta Neuropathology. 1984;64:177–191
  43. Auer RN, Olsson Y, Siesjo BK. Hypoglycemic brain injury in the rat. Correlation of density of brain damage with the EEG isoelectric time: a quantitative study. Diabetes. 1984;33:1090–1098
  44. Suh SW, Aoyama K, Chen Y, et al. Hypoglycemic neuronal death and cognitive impairment are prevented by poly(ADP-ribose) polymerase inhibitors administered after hypoglycemia. Journal of Neuroscience. 2003;23:10681–10690
  45. Auer RN, Hugh J, Cosgrove E, et al. Neuropathologic findings in three cases of profound hypoglycemia. Clinical Neuropathology. 1989;8:63–68
  46. Arky RA, Veverbrants E, Abramson EA. Irreversible hypoglycemia. A complication of alcohol and insulin. Journal of American Medical Association. 1968;206:575–578
  47. Patrick AW, Campbell IW. Fatal hypoglycaemia in insulin-treated diabetes mellitus: clinical features and neuropathological changes. Diabetes Medicine. 1990;7:349–354
  48. Swanson RA, Ying W, Kauppinen TM. Astrocyte influences on ischemic neuronal death. Current Molecular Medicine. 2004;4:193–205
  49. McNay EC, Williamson A, McCrimmon RJ, et al. Cognitive and neural hippocampal effects of long-term moderate recurrent hypoglycemia. Diabetes. 2006;55:1088–1095
  50. Yamada KA, Rensing N, Izumi Y, et al. Repetitive hypoglycemia in young rats impairs hippocampal long-term potentiation. Pediatric Research. 2004;55:372–379
  51. Laitinen T, Lyyra-Laitinen T, Huopio H, et al. Electrocardiographic alterations during hyperinsulinemic hypoglycemia in healthy subjects. Annals of Noninvasive Electrocardiology. 2008;13:97–105
  52. Lindgren M, Eckert B, Stenberg G, et al. Restitution of neurophysiological functions, performance, and subjective symptoms after moderate insulin-induced hypoglycaemia in non-diabetic men. Diabetes Medicine. 1996;13:218–225
  53. Tallroth G, Lindgren M, Stenberg G, et al. Neurophysiological changes during insulin-induced hypoglycaemia and in the recovery period following glucose infusion in type 1 (insulin-dependent) diabetes mellitus and in normal man. Diabetologia. 1990;33:319–323
  54. Robinson AM, Parkin HM, Macdonald IA, et al. Antecedent hypoglycaemia in non-diabetic subjects reduces the adrenaline response for 6 days but does not affect the catecholamine response to other stimuli. Clinical Science (London). 1995;89:359–366
  55. Langan SJ, Deary IJ, Hepburn DA, et al. Cumulative cognitive impairment following recurrent severe hypoglycaemia in adult patients with insulin-treated diabetes mellitus. Diabetologia. 1991;34:337–344
  56. Lincoln NB, Faleiro RM, Kelly C, et al. Effect of long-term glycemic control on cognitive function. Diabetes Care. 1996;19:656–658
  57. Effects of intensive diabetes therapy on neuropsychological function in adults in the Diabetes Control and Complications Trial. Annals of Internal Medicine. 1996;124:379–388
  58. Austin EJ, Deary IJ. Effects of repeated hypoglycemia on cognitive function: a psychometrically validated reanalysis of the Diabetes Control and Complications Trial data. Diabetes Care. 1999;22:1273–1277
  59. Reichard P, Pihl M. Mortality and treatment side-effects during long-term intensified conventional insulin treatment in the Stockholm Diabetes Intervention Study. Diabetes. 1994;43:313–317
  60. Jacobson AM, Musen G, Ryan CM, et al. Long-term effect of diabetes and its treatment on cognitive function. New England Journal of Medicine. 2007;356:1842–1852
  61. Deary IJ, Frier BM. Severe hypoglycaemia and cognitive impairment in diabetes. British Medical Journal. 1996;313:767–768
  62. Soltesz G, Acsadi G. Association between diabetes, severe hypoglycaemia, and electroencephalographic abnormalities. Archives of Diseases in Childhood. 1989;64:992–996
  63. MacLeod KM, Hepburn DA, Deary IJ, et al. Regional cerebral blood flow in IDDM patients: effects of diabetes and of recurrent severe hypoglycaemia. Diabetologia. 1994;37:257–263
  64. Dejgaard A, Gade A, Larsson H, et al. Evidence for diabetic encephalopathy. Diabetes Medicine. 1991;8:162–167
  65. Reske-Nielsen E, Lundbaek K. Diabetic encephalopathy. Diffuse and focal lesions of the brain in long-term diabetes. Acta Neurologica Scandinavica. Supplementum. 1963;39(Suppl.):4–90
  66. Mori F, Nishie M, Houzen H, et al. Hypoglycemic encephalopathy with extensive lesions in the cerebral white matter. Neuropathology. 2006;26:147–152
  67. Ko SB, Bae HJ, Lee SH, et al. Teaching NeuroImage: hippocampal involvement in a patient with hypoglycemic coma. Neurology. 2008;71:e63
  68. Auer RN. Hypoglycemic brain damage. Forensic Science International. 2004;146:105–110
  69. Bree AJ, Puente ET, Daphna-Iken D, et al. Diabetes increases brain damage caused by severe hypoglycemia. American Journal of Physiology Endocrinology and Metabolism. 2009;
  70. Robinson R, Krishnakumar A, Paulose CS. Enhanced dopamine D1 and D2 receptor gene expression in the hippocampus of hypoglycaemic and diabetic rats. Cellular and Molecular Neurobiology. 2009;29:365–372
  71. Simpson IA, Appel NM, Hokari M, et al. Blood-brain barrier glucose transporter: effects of hypo- and hyperglycemia revisited. Journal of Neurochemistry. 1999;72:238–247
  72. Lecomte P, Foubert L, Nobels F, et al. Dynamic tight glycemic control during and after cardiac surgery is effective, feasible, and safe. Anesthesia and Analgesia. 2008;107:51–58
  73. Griesdale DE, de Souza RJ, van Dam RM, et al. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. Canadian Medical Association Journal. 2009;180:821–827
  74. Krinsley JS, Grover A. Severe hypoglycemia in critically ill patients: risk factors and outcomes. Critical Care Medicine. 2007;35:2262–2267
  75. Waeschle RM, Moerer O, Hilgers R, et al. The impact of the severity of sepsis on the risk of hypoglycaemia and glycaemic variability. Critical Care. 2008;12:R129
  76. Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. New England Journal of Medicine. 2008;358:125–139
  77. Krinsley JS. The severity of sepsis: yet another factor influencing glycemic control. Critical Care. 2008;12:194
  78. Gill RQ, Sterling RK. Acute liver failure. Journal of Clinical Gastroenterology. 2001;33:191–198
  79. Van den Bergh G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. New England Journal of Medicine. 2006;354:449–461
  80. Weissenborn K, Bokemeyer M, Krause J, et al. Neurological and neuropsychiatric syndromes associated with liver disease. AIDS (London, England). 2005;19(Suppl. 3):S93–S98
  81. Vogelzang M, Loef BG, Regtien JG, et al. Computer-assisted glucose control in critically ill patients. Intensive Care Medicine. 2008;34:1421–1427
  82. Vriesendorp TM, van Santen S, DeVries JH, et al. Predisposing factors for hypoglycemia in the intensive care unit. Critical Care Medicine. 2006;34:96–101
  83. Smith WD, Winterstein AG, Johns T, et al. Causes of hyperglycemia and hypoglycemia in adult inpatients. American Journal of Health-System Pharmacy. 2005;62:714–719
  84. Henry L, Dunning E, Halpin L, et al. Nurses' perceptions of glycemic control in patients who have undergone cardiac surgery. Clinical Nurse Specialist. 2008;22:271–277
  85. Goldstein SA, Elwyn DH. The effects of injury and sepsis on fuel utilization. Annual Review of Nutrition. 1989;9:445–473
  86. Adam-Perrot A, Clifton P, Brouns F. Low-carbohydrate diets: nutritional and physiological aspects. Obesity Reviews. 2006;7:49–58
  87. Kagansky N, Levy S, Rimon E, et al. Hypoglycemia as a predictor of mortality in hospitalized elderly patients. Archives of Internal Medicine. 2003;163:1825–1829
  88. Van den BG, Wilmer A, Milants I, et al. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes. 2006;55:3151–3159
  89. Vriesendorp TM, DeVries JH, van Santen S, et al. Evaluation of short-term consequences of hypoglycemia in an intensive care unit. Critical Care Medicine. 2006;34:2714–2718
  90. Finfer S, Chittock DR, Su SY, et al. Intensive versus conventional glucose control in critically ill patients. New England Journal of Medicine. 2009;360:1283–1297
  91. Krinsley JS. Glycemic variability: a strong independent predictor of mortality in critically ill patients. Critical Care Medicine. 2008;36:3008–3013
  92. Gunther ML, Jackson JC, Ely EW. Loss of IQ in the ICU brain injury without the insult. Medic Hypotheses. 2007;69:1179–1182
  93. Hopkins RO, Jackson JC. Long-term neurocognitive function after critical illness. Chest. 2006;130:869–878
  94. Malone JI, Hanna S, Saporta S, et al. Hyperglycemia not hypoglycemia alters neuronal dendrites and impairs spatial memory. Pediatrics Diabetes. 2008;9:531–539
  95. Suh SW, Gum ET, Hamby AM, et al. Hypoglycemic neuronal death is triggered by glucose reperfusion and activation of neuronal NADPH oxidase. Journal of Clinical Investigation. 2007;117:910–918
  96. Tanaka Y, Takata T, Satomi T, et al. The double-edged effect of insulin on the neuronal cell death associated with hypoglycemia on the hippocampal slice culture. The Kobe Journal of Medical Science. 2008;54:E97–107
  97. Gonder-Frederick LA, Zrebiec JF, Bauchowitz AU, et al. Cognitive function is disrupted by both hypo- and hyperglycemia in school-aged children with type 1 diabetes: a field study. Diabetes Care. 2009;32:1001–1006
  98. Wessels AM, Scheltens P, Barkhof F, et al. Hyperglycaemia as a determinant of cognitive decline in patients with type 1 diabetes. European Journal of Pharmacology. 2008;585:88–96
  99. Van den Berghe G, Schoonheydt K, Becx P, et al. Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology. 2005;64:1348–1353
  100. Eslami S, de Keizer NF, de Jonge E, et al. A systematic review on quality indicators for tight glycaemic control in critically ill patients: need for an unambiguous indicator reference subset. Critical Care. 2008;12:R139

PII: S1521-6896(09)00066-4

doi: 10.1016/j.bpa.2009.09.002

Best Practice & Research Clinical Anaesthesiology
Volume 23, Issue 4 , Pages 473-485 , December 2009

Article Tools

* Image Usage & Resolution